tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
Advertisement

Keymed Biosciences, Inc. (2162) Ratios

Compare
1 Followers

Keymed Biosciences, Inc. Ratios

HK:2162's free cash flow for Q2 2025 was ¥0.93. For the 2025 fiscal year, HK:2162's free cash flow was decreased by ¥ and operating cash flow was ¥-0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.30 9.36 8.72 31.96 4.75
Quick Ratio
3.15 9.16 8.60 31.81 4.66
Cash Ratio
0.56 2.71 1.59 13.57 2.49
Solvency Ratio
-0.36 -0.32 -0.46 -13.41 -0.50
Operating Cash Flow Ratio
-0.49 -0.97 -1.06 -1.92 -1.49
Short-Term Operating Cash Flow Coverage
-0.77 -6.63 -6.57 -388.13 -2.82
Net Current Asset Value
¥ 1.74B¥ 2.04B¥ 2.72B¥ 3.29B¥ -1.24B
Leverage Ratios
Debt-to-Assets Ratio
0.20 0.11 0.03 <0.01 0.13
Debt-to-Equity Ratio
0.30 0.14 0.04 0.01 -0.06
Debt-to-Capital Ratio
0.23 0.12 0.04 0.01 -0.07
Long-Term Debt-to-Capital Ratio
0.09 0.10 <0.01 0.00 0.00
Financial Leverage Ratio
1.52 1.30 1.18 1.08 -0.48
Debt Service Coverage Ratio
-1.23 -4.30 -3.80 -330.85 -14.11
Interest Coverage Ratio
0.00 -25.19 -35.94 -348.65 -56.24
Debt to Market Cap
0.04 0.03 <0.01 <0.01 <0.01
Interest Debt Per Share
2.87 1.67 0.50 0.31 0.30
Net Debt to EBITDA
0.22 1.60 1.86 0.38 0.17
Profitability Margins
Gross Profit Margin
97.15%89.59%97.42%84.40%0.00%
EBIT Margin
-146.24%-95.72%-295.19%-3520.03%0.00%
EBITDA Margin
-134.18%-76.19%-259.09%-3500.97%0.00%
Operating Profit Margin
-144.37%-122.79%-295.19%-3520.03%0.00%
Pretax Profit Margin
-118.81%-100.59%-303.41%-3530.12%0.00%
Net Profit Margin
-120.35%-101.49%-307.92%-3535.39%0.00%
Continuous Operations Profit Margin
-120.27%-101.04%-303.41%-3530.12%0.00%
Net Income Per EBT
101.30%100.89%101.49%100.15%101.70%
EBT Per EBIT
82.29%81.92%102.78%100.29%101.76%
Return on Assets (ROA)
-5.56%-9.25%-7.84%-99.08%-157.14%
Return on Equity (ROE)
-9.08%-12.03%-9.22%-106.78%76.08%
Return on Capital Employed (ROCE)
-9.07%-12.18%-8.31%-101.55%-178.94%
Return on Invested Capital (ROIC)
-8.02%-12.02%-8.27%-101.37%-164.90%
Return on Tangible Assets
-5.57%-9.26%-7.84%-99.11%-157.17%
Earnings Yield
-1.44%-3.09%-2.62%-86.76%-5.37%
Efficiency Ratios
Receivables Turnover
6.57 12.66 0.00 10.45 0.00
Payables Turnover
0.47 1.25 0.17 6.18 0.00
Inventory Turnover
0.11 0.60 0.06 1.05 0.00
Fixed Asset Turnover
0.41 0.40 0.17 0.36 0.00
Asset Turnover
0.11 0.09 0.03 0.03 0.00
Working Capital Turnover Ratio
0.22 0.13 0.03 0.06 0.00
Cash Conversion Cycle
1.09K 341.72 4.18K 323.72 0.00
Days of Sales Outstanding
42.99 28.83 0.00 34.92 0.00
Days of Inventory Outstanding
1.47K 604.75 6.28K 347.87 0.00
Days of Payables Outstanding
428.77 291.86 2.11K 59.08 0.00
Operating Cycle
1.51K 633.58 6.28K 382.80 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.39 -1.16 -1.54 -1.33 -0.44
Free Cash Flow Per Share
-1.80 -2.63 -2.61 -2.41 -0.51
CapEx Per Share
0.41 1.46 1.07 1.07 0.07
Free Cash Flow to Operating Cash Flow
1.29 2.26 1.70 1.81 1.17
Dividend Paid and CapEx Coverage Ratio
-3.41 -0.79 -1.44 -1.24 -6.00
Capital Expenditure Coverage Ratio
-3.41 -0.79 -1.44 -1.24 -6.00
Operating Cash Flow Coverage Ratio
-0.49 -0.73 -3.30 -5.47 -1.79
Operating Cash Flow to Sales Ratio
-0.85 -0.86 -4.02 -1.95 0.00
Free Cash Flow Yield
-4.27%-5.90%-5.80%-8.62%-0.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-34.57 -32.36 -38.17 -1.15 -18.62
Price-to-Sales (P/S) Ratio
46.71 32.84 117.52 40.75 0.00
Price-to-Book (P/B) Ratio
7.20 3.89 3.52 1.23 -14.16
Price-to-Free Cash Flow (P/FCF) Ratio
-42.25 -16.94 -17.26 -11.60 -111.33
Price-to-Operating Cash Flow Ratio
-48.67 -38.30 -29.26 -20.93 -129.89
Price-to-Earnings Growth (PEG) Ratio
-1.12 -2.01 0.40 >-0.01 -0.05
Price-to-Fair Value
7.20 3.89 3.52 1.23 -14.16
Enterprise Value Multiple
-35.40 -41.50 -43.50 -0.78 -19.56
Enterprise Value
19.94B 11.20B 11.28B 3.01B 15.37B
EV to EBITDA
-63.77 -41.50 -43.50 -0.78 -19.56
EV to Sales
22.86 31.62 112.70 27.31 0.00
EV to Free Cash Flow
-23.33 -16.31 -16.55 -7.77 -110.38
EV to Operating Cash Flow
-32.97 -36.87 -28.06 -14.03 -128.77
Tangible Book Value Per Share
9.40 11.42 12.78 22.66 -4.04
Shareholders’ Equity Per Share
9.43 11.43 12.79 22.70 -4.04
Tax and Other Ratios
Effective Tax Rate
-0.01 >-0.01 -0.01 >-0.01 -0.02
Revenue Per Share
1.63 1.35 0.38 0.69 0.00
Net Income Per Share
-1.96 -1.37 -1.18 -24.24 -3.07
Tax Burden
1.01 1.01 1.01 1.00 1.02
Interest Burden
0.69 1.05 1.03 1.00 5.50
Research & Development to Revenue
0.88 1.68 5.07 3.25 0.00
SG&A to Revenue
0.21 0.50 1.34 1.18 0.00
Stock-Based Compensation to Revenue
0.04 0.11 0.49 1.06 0.00
Income Quality
2.35 0.85 1.32 0.06 0.15
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis